PUBLIC PORTAL

PUBLIC PORTAL

MEDICALLY REVIEWED

The Newest JAK inhibitor for Psoriatic Arthritis: Upadacitinib (Rinvoq)

psoriasis, psoriatic arthritis, crossed arms

The disease burden and current treatment landscape
Psoriatic arthritis (PsA) is a chronic inflammatory musculoskeletal disease with complex clinical manifestations such as plaque psoriasis, dactylitis and enthesitis. Patients with PsA often experience fatigue, physical function limitations, sleep disturbance, as well as diminished work capacity and social participation. The . . .

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

Earthquake rescue Turkey

Treatments for earthquake survivors

Surviving an earthquake can be a traumatic and life-changing event, and the aftermath can have a profound impact on a person’s physical and mental health. The death toll from the earthquake that rocked Turkey and Syria continues to rise. 

Read More »

People also read: